A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Asan Medical Center
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
AstraZeneca
Memorial Sloan Kettering Cancer Center